{"id":"W2770849724","doi":"10.3389/fonc.2017.00273","title":"Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics","year":2017,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":286,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Repurposing; Drug repositioning; Leverage (statistics); Clinical trial; Medicine; Cancer drugs; Drug development; Drug; Business; Approved drug; Alternative medicine; Government (linguistics); Pharmacology; Computer science; Engineering; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001438379,0.0005300883,0.003357133,0.0009162436,0.0001776227,0.0001240886,0.0006416778,0.001033943,0.0001208554],"category_scores_gemma":[0.0001503925,0.0006380955,0.0003015566,0.0002030951,0.0003442111,0.0002674636,0.0003032978,0.001160379,0.00002812715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001860641,"about_ca_system_score_gemma":0.0006954378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002921671,"about_ca_topic_score_gemma":0.0002741956,"domain_scores_codex":[0.9964579,0.0001208472,0.001585754,0.001011571,0.00003775546,0.0007861481],"domain_scores_gemma":[0.9975718,0.0002093826,0.00148578,0.0005672807,0.00001537788,0.0001503263],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000298815,0.00007009119,0.001077794,0.002351819,0.0001125358,0.00001827102,0.001719358,0.00000363307,2.124859e-7,0.006437789,0.001808082,0.9863705],"study_design_scores_gemma":[0.0009249436,0.0000456224,0.0001599018,0.001448187,0.00004973925,0.00001027164,0.00007319303,0.0008311559,8.613883e-7,0.01537373,0.9804485,0.000633901],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001719223,0.9782785,0.00003953914,0.0003293271,0.003157222,0.0008131068,0.0002447052,0.00001776806,0.01540058],"genre_scores_gemma":[0.0008506463,0.994565,0.0008082342,0.001389699,0.000552117,0.0003032986,0.00001750252,0.00009067983,0.001422812],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9857366,"threshold_uncertainty_score":0.999607,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1036281468605397,"score_gpt":0.3817537428207261,"score_spread":0.2781255959601864,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}